Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

Original Article
Invasive hemodynamic monitoring for fluid management in septic shock patients
Aim: Sepsis is still one of the most common causes of death, despite advances in treatment and technologies. Invasive monitoring in sepsis can improve survival. In this study, we aimed to compare the efficacy of hemodynamic monitoring in the fluid treatment of patients with septic shock. Material and Method: Forty septic shock patients were divided into two groups. Group I (n=20) was monitored with central venous pressure, and Group II (n=20) with a cardiac output device (EV1000). Arterial blood gases were analyzed four times daily for the groups, and lactate values, diuresis status, need for dialysis, and inotrope need was recorded. For Group I, the central venous pressure and mean arterial pressure values were recorded for group II, cardiac output, cardiac index, stroke volume, stroke volume index, and mean arterial pressure values. Results: There was a significant difference between the mean arterial pressures of the groups on the 1st and 2nd days (p=0.034 and p=0.026, respectively). In Group II, mean arterial pressures were higher on days 1 and 2. There was no significant difference between the other data recorded. Conclusion: We observed no significant difference between central venous pressure monitoring and invasive monitoring in septic shock patient follow-up.

1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines For Management Of Severe Sepsis And SepticShock, 2012. Intensive Care Med 2013; 39: 165-228.
2. Singer M, Deutschman CS, Seymour CW, et al. The Third InternationalConsensus Definitions For Sepsis And Septic Shock (Sepsis-3). JAMA2016; 315: 801-10.
3. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing A NewDefinition And Assessing New Clinical Criteria For Septic Shock: For TheThird International Consensus Definitions For Sepsis And Septic Shock(Sepsis-3). JAMA 2016; 315: 775-87.
4. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment Of Clinical CriteriaFor Sepsis: For The Third International Consensus Definitions For SepsisAnd Septic Shock (Sepsis-3) [Published Correction Appears İn. JAMA2016; 2431: 762-74.
5. Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin İn Septic Shock Afterİntravascular Volume Resuscitation. Lancet 2002; 360: 1395-6.
6. Aykaç, Z: Z., & Arslantaş, MK. Fluid Therapy And Management (II)Monitoring And Prediction Of Fluid Responsiveness. GKDA Derg 2018;24: 1-10.
7. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis CampaignGuidelines For Management Of Severe Sepsis And Septic Shock. IntensiveCare Med 2004; 30: 536-55.
8. Bone R, Balk R, Cerra F, et al. Definitions For Sepsis And Organ FailureAnd Guidelines For The Use Of İnnovative Therapies in Sepsis. TheACCP/SCCM Consensus Conference Committee. American College OfChest Physicians/Society Of Critical Care Medicine 1992. Chest 2009;136: E28.
9. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy in TheTreatment Of Severe Sepsis And Septic Shock. N Engl J Med 2001; 345:1368-77.
10. Peake SL, Delaney A, Bailey M, et al. Goal-Directed Resuscitation ForPatients With Early Septic Shock. N Engl J Med 2014; 371: 1496-506.
11. Process Investigators, Yealy DM, Kellum JA, et al. A Randomized TrialOf Protocol-Based Care For Early Septic Shock. N Engl J Med 2014; 370:1683-93.
12. Mouncey PR, Osborn TM, Power GS, et al. Trial Of Early, Goal-DirectedResuscitation For Septic Shock. N Engl J Med 2015; 372: 1301-11.
13. Ferreira FL, Bota DP, Bross A, et al. Serial Evaluation Of The SOFA ScoreTo Predict Outcome İn Critically İll Patients. JAMA 2001; 286: 1754-8.
14. Bersten AD, Holt AW. Vasoactive Drugs And The İmportance Of RenalPerfusion Pressure. New Horizons (Baltimore, Md) 1995; 3: 650-61.
15. Ledoux D, Astiz ME, Carpati CM, et al. Effects Of Perfusion Pressure OnTissue Perfusion İn Septic Shock. Crit Care Med Baltimore 2000; 28: 2729-32.
16. Harris RL, Musher DM, Bloom K, et al. Manifestations Of Sepsis. ArchIntern Med 1987; 147: 1895-906.
17. Gattinoni L, Brazzi L, Pelosi P, et al. A Trial Of Goal-OrientedHemodynamic Therapy İn Critically İll Patients. New Engl J Med 1995;333: 1025-32.
Volume 2, Issue 4, 2022
Page : 131-134